Aimed Bio Inc. (KOSDAQ:0009K0)
South Korea flag South Korea · Delayed Price · Currency is KRW
33,750
-450 (-1.32%)
At close: Jun 2, 2026

Aimed Bio Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
2,182,6523,695,395---
Enterprise Value
2,101,1513,612,198---
Last Close Price
33750.0057600.00---
PE Ratio
535.77735.76---
PS Ratio
40.2778.16---
PB Ratio
11.3719.19---
P/TBV Ratio
11.4719.35---
P/FCF Ratio
176.57211.09---
P/OCF Ratio
166.16206.91---
EV/Sales Ratio
38.7776.40---
EV/EBITDA Ratio
108.18163.07---
EV/EBIT Ratio
117.11173.93---
EV/FCF Ratio
169.98206.34---
Debt / Equity Ratio
0.010.010.010.050.11
Debt / EBITDA Ratio
0.090.050.40--
Debt / FCF Ratio
0.140.07---
Net Debt / Equity Ratio
-0.42-0.88-0.78-0.98-0.53
Net Debt / EBITDA Ratio
-4.20-7.66-33.233.211.04
Net Debt / FCF Ratio
-6.59-9.696.884.991.15
Asset Turnover
-0.380.340.01-
Quick Ratio
12.7231.1716.914.246.99
Current Ratio
14.2731.4317.024.257.13
Return on Equity (ROE)
3.44%4.23%-10.62%-66.75%-
Return on Assets (ROA)
-10.55%-0.73%-24.04%-
Return on Capital Employed (ROCE)
9.30%10.70%-0.90%-35.60%-55.90%
Earnings Yield
0.19%0.14%---
FCF Yield
0.57%0.47%---
Buyback Yield / Dilution
-60.49%-39.67%-4.02%-2.16%-